Insights into Preservation of Blood Biomarkers in Biobank Samples.
暂无分享,去创建一个
T. Sorsa | P. Nyberg | T. Tervahartiala | Tuula Salo | Petri Lehenkari | P. Åström | K. Juurikka | H. Öhman | Tiina Pekkala
[1] V. Farutin,et al. Variable blood processing procedures contribute to plasma proteomic variability , 2021, Clinical Proteomics.
[2] M. Gómez,et al. Phenotypic and functional stability of leukocytes from human peripheral blood samples: considerations for the design of immunological studies , 2019, BMC Immunology.
[3] K. Grankvist,et al. Preanalytical aspects on short- and long-term storage of serum and plasma , 2018, Diagnosis.
[4] M. Ivarsson,et al. Levels of matrix metalloproteinases differ in plasma and serum – aspects regarding analysis of biological markers in cancer , 2016, British Journal of Cancer.
[5] T. Salo,et al. Matrix metalloproteinase 8 degrades apolipoprotein A‐I and reduces its cholesterol efflux capacity , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[6] V. Speirs,et al. Breast cancer: Investment biobanking—increased returns from tissue samples , 2013, Nature Reviews Clinical Oncology.
[7] H. Portugal,et al. Stability study of 81 analytes in human whole blood, in serum and in plasma. , 2012, Clinical biochemistry.
[8] A. Leino,et al. Stability of chemical and immunochemical analytes in uncentrifuged plasma samples , 2009, Annals of clinical biochemistry.
[9] T. Salo,et al. Matrix Metalloproteinase-8 Is Expressed in Rheumatoid Synovial Fibroblasts and Endothelial Cells , 1997, The Journal of Biological Chemistry.